FDA Inspection 1207908 — Megafine Pharma (P) Limited

Megafine Pharma (P) Limited — FEI 3006688078

The FDA completed an inspection of Megafine Pharma (P) Limited on May 12, 2023 in Vapi. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
May 12, 2023
Fiscal Year
2023
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Vapi (India)